Neurol. praxi. 2012;13(2):109-111

Cranial neuropathy in a patient with Burkitt lymphoma infiltrating the cauda equina

MUDr.Martin Pail1,2, MUDr.Ivica Husárová1, MUDr.Marta Pažourková3, MUDr.Eduard Minks1
1 1. neurologická klinika LF MU a FN u sv. Anny v Brně
2 Středoevropský technologický institut (CEITEC), Masarykova univerzita, Brno
3 Klinika zobrazovacích metod LF MU a FN u sv. Anny v Brně

Burkitt lymphoma is a high grade B-cell hemathologic malignity and a subtype of Non-Hodgkin lymphoma. Primary leptomeningeal

lymphoma is a rare syndrome, characterized by lymphomatous meningeal infiltration with no evidence of either systemic lymphoma or

parenchymal central nervous system lymphoma. Malignant cells are found in the cerebrospinal fluid, within and around the meninges

only, with no invasion of parenchymal tissue. The infiltration affects also peripheral and cranial nerves or spinal roots. Polyneuropathic

syndrome is a common clinical manifestation of the disease. Nevertheless, the secondary metastatic invasion of the parenchymal central

nervous system is possible.

Keywords: Burkitt’s lymphoma, primary leptomeningeal lymphoma, polyneuropathy syndrome, cerebrospinal fluid, cranial neuropathy

Published: April 23, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pail M, Husárová I, Pažourková M, Minks E. Cranial neuropathy in a patient with Burkitt lymphoma infiltrating the cauda equina. Neurol. praxi. 2012;13(2):109-111.
Download citation

References

  1. Billaud M, Rousset F, Calender A, Cordier M, Aubry JP, Laisse V, Lenoir GM. Low expression of lymphocyte function-associated antigen (LFA) -1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus. Blood 1990; 75(9): 1827. Go to original source...
  2. Ambler Z. Lymfomatosní neuropatie (neurolymfomatóza) - kazuistika. Cesk Slov neurol N 2010; 73/106/(6): 725-727.
  3. Arányi Z, Kovács T, Sipos I, Bereczki D. Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings. Eur J Neurol 2011 Jun 1. doi: 10.1111/j.1468-1331. 2011.03445.x. [Epub ahead of print]. Go to original source...
  4. Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood 2004; 104(10): 3009. Go to original source... Go to PubMed...
  5. Cappellari M, Benedetti F, Fiaschi A, Benedetti MD. Multiple radiculopathy as the presenting manifestation of primary spinal leptomeningeal B cell lymphoma detected by flow cytometry of cerebrospinal fluid. Neurol Sci. 2011 DOI 10.1007/s10072-011-0613-5. Go to original source... Go to PubMed...
  6. Carlson CL, Hartman R, Ly JQ, Beall DP. Primary leptomeningeal lymphoma of the lumbar spine. Clin Imaging 2003; 27: 389-393. Go to original source... Go to PubMed...
  7. Lachance DH, O'Neill BP, Macdonald DR, Jaeckle KA, Witzig TE, CY Li and JB Posner. Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature. Neurology 1991; 41(1): 95-100. Go to original source... Go to PubMed...
  8. Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A. Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2011; 76(3): 294-300. Go to original source... Go to PubMed...
  9. Ho TW, Willison HJ, Nachamkin I, Li CY, Veitch J, Ung H, Wang GR, Liu RC, Cornblath DR, Asbury AK, Griffin JW, McKhann GM. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol 1999; 45(2): 168-173. Go to original source... Go to PubMed...
  10. Hughes RA, Hadden RD, Gregson NA, Smith KJ. Pathogenesis of Guillain-Barré syndrome. J Neuroimmunol 1999 Dec; 100(1-2): 74-97. Review. Go to original source... Go to PubMed...
  11. Kelly JJ, Karcher DS. Lymphoma and peripheral neuropathy: a clinical review. Muscle Nerve. 2005; 31(3): 301-313. Go to original source... Go to PubMed...
  12. Levitt LJ, Dawson DM, Rosenthal DS, Moloney WC. CNS involvement in the non-Hodgkin's lymphomas. Cancer 1980; 45(3): 545. Go to original source...
  13. Lo YL Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve. 2007; 36(5): 615-627.
  14. Minks E, Bareš M. Elektromyografická diagnostika u akutní zánětlivé demyelinizační polyradikuloneuritidy. Retrospektivní hodnocení a srovnání s mezinárodními diagnostickými kritérii Neurol. praxi 2007; 1: 43-48.
  15. Moran AP, Prendergast MM. Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity. J Autoimmun. 2001; 16(3): 241-256. Go to original source... Go to PubMed...
  16. Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, Marcos-Gragera R, Maynadié M, Simonetti A, Lutz JM, Berrino F. HAEMACARE Working Group. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 2010; 116: 3724. Go to original source... Go to PubMed...
  17. Susuki K, Koga M, Hirata K, Isogai E, Yuki N. A Guillain-Barré syndrome variant with prominent facial diplegia. J Neurol 2009; 256(11): 1899-1905. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.